Furthermore, DA receptor regulation should be explored, as emerging research has suggested that a complex interplay between DAT and DA receptors occurs, along with changes in receptor expression and signaling pathways, which often challenges PD pathophysiology and treatment [119]. Here, SLC6A3 is linked to Parkinson disease.